Topical amitriptyline-ketamine for the treatment of brachioradial pruritus

JAMA Dermatology

Volumn 149, Issue 2, 2013, Pages 148-150

  Poterucha, Timothy J ^b   Murphy, Sinead L ^c   Davis, Mark D P ^a   Sandroni, Paola ^a   Rho, Richard H ^a   Warndahl, Roger A ^a   Weiss, William T ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c AMHERST COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CAPSAICIN; DESLORATADINE; DOXEPIN; HYDROXYZINE; KETAMINE; PIMECROLIMUS; ULOBETASOL PROPIONATE;

ADULT; ARTICLE; BRACHIORADIAL PRURITUS; CASE REPORT; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; LIGHT EXPOSURE; MALE; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRURITUS; QUANTITATIVE ANALYSIS; SPINE RADIOGRAPHY; THERMAL EXPOSURE; THERMOREGULATION; TREATMENT FAILURE; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; AMITRIPTYLINE; ANALGESICS; ANALGESICS, NON-NARCOTIC; FOREARM; HUMANS; KETAMINE; MALE; PRURITUS; TREATMENT OUTCOME;

EID: 84874255167     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamadermatol.646     Document Type: Article

References (19)

1. Illigens BM, Gibbons CH. Sweat testing to evaluate autonomic function. Clin Auton Res. 2009;19(2):79-87.
2. Low PA. Autonomic nervous system function. J Clin Neurophysiol. 1993;10(1): 14-27.
3. Marziniak M, Phan NQ, Raap U, et al. Brachioradial pruritus as a result of cervical spine pathology: the results of a magnetic resonance tomography study. J Am Acad Dermatol. 2011;65(4):756-762.
4. Yosipovitch G, Greaves M. Definitions of itch. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F, eds. Itch: Basic Mechanisms and Therapy. New York, NY: Marcel Dekker Inc; 2004:3.
5. Binder A, Koroschetz J, Baron R. Disease mechanisms in neuropathic itch. Nat Clin Pract Neurol. 2008;4(6):329-337.
6. Atanassoff PG, Brull SJ, Zhang J, Greenquist K, Silverman DG, Lamotte RH. Enhancement of experimental pruritus and mechanically evoked dysesthesiae with local anesthesia. Somatosens Mot Res. 1999;16(4):291-298.
7. Wallengren J. Neuroanatomy and neurophysiology of itch. Dermatol Ther. 2005; 18(4):292-303.
8. Cevikbas F, Steinhoff M, Ikoma A. Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development. CNS Neurosci Ther. 2011; 17(6):742-749.
9. Bueller HA, Bernhard JD, Dubroff LM. Gabapentin treatment for brachioradial pruritus. J Eur Acad Dermatol Venereol. 1999;13(3):227-228.
10. Warncke T, Jørum E, Stubhaug A. Local treatment with the N-methyl-Daspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action. Neurosci Lett. 1997;227(1):1-4.
11. Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C III. Inhibition of neuronal Na- channels by antidepressant drugs. J Pharmacol Exp Ther. 1998;284(1):208- 214.
12. Oatway M, Reid A, Sawynok J. Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat. Anesth Analg. 2003;97(1):168-173.
13. Barton DL, Wos EJ, Qin R, et al. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011;19(6):833-841.
14. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebocontrolled trial. Anesthesiology. 2005;103(1):140-146.
15. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain. 2005;6(10):644- 649.
16. Lynch ME, Clark AJ, Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain. 2003;19(5):323-328.
17. Sandroni P, Davis MD. Combination gel of 1% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain: a new treatment option? Arch Dermatol. 2006;142(3):283-286.
18. Lehman JS, Sciallis GF. Effective use of topical amitriptyline hydrochloride 2.5% and ketamine hydrochloride 0.5% for analgesia in refractory proctodynia. J Drugs Dermatol. 2008;7(9):887-889.
19. Lockhart E. Topical combination of amitriptyline and ketamine for post herpetic neuralgia. J Pain. 2004;5(3)(suppl 1):S82.